Monitoring Strategy Baseline (before starting): Complete pain assessment with validated tools Neurological examination Basic metabolic panel, HbA1c (if diabetic), vitamin B12, TSH INR if on warfarin Cardiovascular risk assessment Ongoing: Pain assessment every 4-8 weeks initially, then every 12 weeks INR weekly 2 weeks then monthly if on warfarin Neurological examination every 6-12 months Annual laboratory monitoring for long-term use 4
When we're finished, we flush the IV line with saline, remove the catheter, and apply a small bandage
According to the Ozempic SmPC, semaglutide has a half-life of approximately one week , which allows for once-weekly dosing but also means the medication remains in the system for an extended period after the last dose
Arakawa T, Satoh H, Nakamura A, et al
& Suhrcke, M